GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Liaoning Chengda Biotechnology Co Ltd (SHSE:688739) » Definitions » Market Cap

Liaoning Chengda Biotechnology Co (SHSE:688739) Market Cap : ¥11,631 Mil (As of Jul. 21, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Liaoning Chengda Biotechnology Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Liaoning Chengda Biotechnology Co's share price for the quarter that ended in Mar. 2025 was ¥26.87. Liaoning Chengda Biotechnology Co's Shares Outstanding (EOP) for the quarter that ended in Mar. 2025 was 416 Mil. Therefore, Liaoning Chengda Biotechnology Co's market cap for the quarter that ended in Mar. 2025 was ¥11,190 Mil.

Liaoning Chengda Biotechnology Co's quarterly market cap declined from Sep. 2024 (¥11,852 Mil) to Dec. 2024 (¥10,736 Mil) but then increased from Dec. 2024 (¥10,736 Mil) to Mar. 2025 (¥11,190 Mil).

Liaoning Chengda Biotechnology Co's annual market cap increased from Dec. 2022 (¥12,668 Mil) to Dec. 2023 (¥13,539 Mil) but then declined from Dec. 2023 (¥13,539 Mil) to Dec. 2024 (¥10,736 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Liaoning Chengda Biotechnology Co's Enterprise Value for Today is ¥6,194 Mil.


Liaoning Chengda Biotechnology Co Market Cap Historical Data

The historical data trend for Liaoning Chengda Biotechnology Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Liaoning Chengda Biotechnology Co Market Cap Chart

Liaoning Chengda Biotechnology Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 31,704.34 12,668.41 13,538.79 10,736.08

Liaoning Chengda Biotechnology Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11,731.40 10,094.75 11,852.17 10,736.08 11,190.01

Competitive Comparison of Liaoning Chengda Biotechnology Co's Market Cap

For the Biotechnology subindustry, Liaoning Chengda Biotechnology Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Liaoning Chengda Biotechnology Co's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Liaoning Chengda Biotechnology Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Liaoning Chengda Biotechnology Co's Market Cap falls into.


;
;

Liaoning Chengda Biotechnology Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Liaoning Chengda Biotechnology Co's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as

Market Cap (A: Dec. 2024 )=Share Price (A: Dec. 2024 )*Shares Outstanding (EOP) (A: Dec. 2024 )
=¥25.78*416.450
=¥10,736

Liaoning Chengda Biotechnology Co's Market Cap for the quarter that ended in Mar. 2025 is calculated as

Market Cap (Q: Mar. 2025 )=Share Price (Q: Mar. 2025 )*Shares Outstanding (EOP) (Q: Mar. 2025 )
=¥26.87*416.450
=¥11,190

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Liaoning Chengda Biotechnology Co  (SHSE:688739) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Liaoning Chengda Biotechnology Co Market Cap Related Terms

Thank you for viewing the detailed overview of Liaoning Chengda Biotechnology Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Liaoning Chengda Biotechnology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1, Xinfang Street, Hunnan New District, Liaoning Province, Shenyang, CHN, 110179
Liaoning Chengda Biotechnology Co Ltd is engaged in the research and development, production and sales of human vaccines.
Executives
Li Ning Director
Cui Jian Wei senior management
Chen Xin senior management
Zhang Shu Min Director
Zhou Li Bao senior management
Yuan De Ming senior management
Gao Jun Director
Yang Xu Director

Liaoning Chengda Biotechnology Co Headlines

No Headlines